Monoxidil 2% is scientifically proven and is FDA approved for hair re-growth. Minoxin is both effective and safe.

Clinical studies of Minoxidil 2% in men were conducted by 27 U.S. medical centres involving over 2300 patients with male pattern baldness. After four months 26% of the patients using Minoxidil 2% had minimal to dense hair growth, compared to those using placebo. By the end of one year 48% of the men in the study, who continued in using Minoxidil 2% rated their hair growth as moderate or better.

Clinical studies of Minoxidil 2% in women were conducted by physicians in 11 U.S. and European medical centers involving over 600 patients with hair loss. After 8 months, 57% of the patients using Minoxidil had minimal to moderate growth.

PRESENTATION:
Minoxin Topical Solution is a clear, colorless liquid, available in a plastic bottle of 60ml with applicators.

COMPOSITION:
Minoxin Topical Solution is available at a concentration of 20mg Minoxidil/ml, in a solution of alcohol 0.6ml and propylene glycol 0.2ml.

Topical application of Minoxidil 2% showed no systemic effect in the prescribed dosage, i.e. 2 (two) applications per day.

PHARMACOKINETICS:
On topical application Minoxidil 2% is poorly absorbed, from normal intact scalp with an average of 1.4% (0.3 to 4.5%) of the total applied dose, reaching systemic circulation .Therefore, 1(one) ml of Minoxidil 2% delivering 20mg Minoxidil to the skin, would result in absorption of approximately 0.280mg of Minoxidil. Local abrasion or dermatitis may enhance absorption. Serum Minoxidil levels resulting from topical administration are governed by the drug's percutaneous absorption rate. Following cessation of topical dosing approximately 95% of systemically absorbed Minoxidil is eliminated within 4 days. Metabolic biotransformation of Minoxidil absorbed following topical application has not been fully determined.

INDICATIONS AND USAGE:
Minoxin (Minoxidil 2%) Topical Solution is indicated for treatment of androgenetic alopecia, expressed in males as baldness of the vertex of the scalp and in females as diffuse hair loss or thinning of frontoparietal areas. At least 4 (four) months of twice daily applications of Minoxin (Minoxidil 2%) are generally required before evidence of hair growth can be expected.

CONTRA-INDICATIONS:
Minoxin (Minoxidil 2%) Topical solution is contra-indicated in patients with a history of hypersensitivity to any component of the preparation.

Use during Pregnancy and Lactation:
Minoxin (Minoxidil 2%) like other drugs should not be used by pregnant and nursing women.

Paediatric Use:
Safety and effectiveness of Minoxidil 2% solution in patients under 18 years of age have not been established.

INTERACTIONS:
There are currently no known interactions associated with the use of Minoxidil topical solution.

DOSAGE AND ADMINISTRATION:
For external use only. Use Minoxin only as directed. Do not apply to any other area of the body. A total dose of 1ml Monoxin should be applied twice daily on the scalp, beginning at the center of the affected area. This dose should be used regardless of the size of the affected area. The total daily dose should not exceed 2ml. To avoid any systemic absorption, wash hands thoroughly after applying Minoxin. Apply Minoxin when the hair and scalp are thoroughly dried. Don't use a hairdryer to speed the drying of Minoxin solution because blowing air on the scalp may decrease the effectiveness of Minoxin.
Over dosage and Accidental Ingestion:
Accidental ingestion may produce systemic effects related to the vasodilatory action of Minoxidil. Signs and symptoms of drug over dosage would most likely be cardiovascular effects associated with fluid retention, lowered. blood pressure and tachycardia. Fluid retention can be managed with appropriate diuretic therapy. Tachycardia can be controlled by administration of a beta-adrenergic blocking agent. Hypotension should be treated by intravenous administration of normal saline. Sympathomimetic drugs, such as norepinephrine and epinephrine should be avoided because of their excessive cardiac stimulating avtivity.

PACK:
Bottle of 60ml (approx.) with applicator.

ADVANTAGES:

• Stimulates hair growth
  
• Male: The condition is known as "Male Pattern Baldness"
  
• Female: The condition is "Thinning of hair or Diffuse Hair Loss".
  
• Stabilizers Falling Hair
  
• FDA approved
  
• Food and drug administration powerful body in U.S.A… gives approval for use only when the product is clinically effective & safe.
• The world renowned (Minoxidil 2%) Solution available all over the world is the only treatment for baldness for both males & females.
  
• Efficacy proven scientifically and supported by clinical studies.
  
• Manufactured by a Reputable Pharmaceutical Company.
  
• Safe
  
• No systemic effects on recommended dosage.
  
• Easy to Use
  
• Applicator provided.